DOT Compliance, Drug Testing, and Transportation Safety Contributor
Michael Torres is a contributor focused on DOT compliance, drug testing, and transportation safety. He writes practical, accessible content for employers managing regulated and safety-sensitive workforces.
“Strong compliance programs work best when they are both defensible and easy to manage day to day.”
FMCSA is withholding over $73 million from New York after a federal audit found 53% of non-domiciled CDLs were illegally issued. Here is what the non-domiciled CDL crackdown means for motor carriers, fleet operators, and employer compliance programs.
The 2026 CVSA International Roadcheck runs May 12–14 with a focus on ELD tampering and cargo securement. Here is what motor carriers need to know and how to prepare your fleet before the 72-hour inspection blitz begins.
The DOT is expanding its drug testing panel to include fentanyl, FMCSA Clearinghouse Phase II is actively downgrading CDLs, and oral fluid testing is on the horizon. Here is what every CDL employer needs to know to stay compliant in 2026.